Find your next M&A target

Target Asia + Worldwide M&A projects with our guidance on matching, planning, due diligence & implementation.

Project details

Japanese lifestyle diseases drug developer seeks financing.

Project region Japan
Industry Biomedicine
Total value of the target N/A
Expected target net rate of return after deducting all taxes and fees N/A
Validity period of pending order 365

CONTACT ADVISOR

  • Simon Laube

    Simon Laube

    Senior Associate, International Business Advisory

Project highlights diabetes - 7 product pipelines - jointly funded by three large companies
Project description

The Japanese company mainly focuses on the development of new medicines for lifestyle diseases such as diabetes, hypertension, and hyperlipidemia. It currently has 7 product pipelines and three products of it have entered the Phase II clinical trial. The company is jointly funded by Innovation Network Corporation of Japan, Takeda and Medipal. Now it seeks financing.

Enquire for more information about our services, and how we can help solve challenges for your organization

Contact Us
The code is case-sensitive